跳至主要内容
临床试验/NCT02545296
NCT02545296已完成不适用

HIV Point-of-Care Tests in Babies Study (BABY) - Operational Evaluation of HIV Point-of-Care Tests for Very Early Infant HIV Diagnostics in Infants Born to HIV Infected Mothers in Mbeya, Tanzania

Michael Hoelscher1 个研究点 分布在 1 个国家目标入组 604 人开始时间: 2015年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
604
试验地点
1
主要终点
Specificity of PoC HIV test

研究概览

简要总结

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, Tanzania.

详细描述

This in-vitro diagnostic (IVD) study in infants born to HIV infected mothers evaluates the reliability and operational feasibility of an HIV Point-of-Care (PoC) test for HIV early infant diagnosis (EID) in a public health setting at obstetric clinics in Mbeya, Tanzania.

Recruitment is planned to take place at 4 obstetric/maternity study sites in and around Mbeya over a time period of 12 months. The HIV PoC test will be validated against the Standard-of-Care diagnostic test, i.e. Dried Blood Spot (DBS) analyses.

The PoC test under investigation is the Xpert HIV-1 Qual produced by Cepheid, Sunnyvale, USA.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
1 Minute 至 48 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • Voluntary and informed consent of the mother for her own study participation (if applicable).
  • Voluntary and informed consent of the legal guardian of the child for participation of the child in the study.
  • Mothers/legal guardians ≥18 years of age.
  • Documented maternal HIV infection.
  • Willingness to consent to HIV testing for the child and herself (if applicable).
  • Willing to consent to active tracing including home tracing.

排除标准

  • Deficiency in the mother, rendering it difficult, if not impossible, for her or her infant to take part in the study or understand the information provided to her. This includes alcoholism, drug dependency as well as psychiatric illnesses, suicidal tendencies or any other inability.
  • Having delivered more than 48h ago
  • Women presenting with an emergency requiring immediate medical assistance if not resolved at study inclusion.
  • Stillbirths
  • Infant requiring emergency care or born with severe malformation.
  • If within the discretion of the investigator based on recommendation of the gynaecologist or paediatrician in charge study participation would possibly add not acceptable risk or burden to the mother or infant (e.g. significant congenital malformation, health deficiencies, very low birth weight less than 1500g)
  • Unlikely to comply with protocol as judged by the principal investigator or his designate

研究组 & 干预措施

In-vitro Diagnostics

Other

All infants are recruited into the same arm.

干预措施: In-vitro Diagnostics (Other)

结局指标

主要结局

Specificity of PoC HIV test

时间窗: Participants are planned to be followed for the duration of 6 weeks, i.e. the time point of the current Standard of Care EID

Specificity of the PoC HIV test

Sensitivity of PoC HIV test

时间窗: Participants are planned to be followed for the duration of 6 weeks, i.e. the time point of the current Standard of Care EID

Sensitivity of the PoC HIV test

次要结局

未报告次要终点

研究者

发起方
Michael Hoelscher
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Michael Hoelscher

Prof Dr

Ludwig-Maximilians - University of Munich

研究点 (1)

Loading locations...

相似试验